Join
Live feed
·
INSIDERFilingvia Quantisnow
Travere Therapeutics Inc. logo

CHIEF FINANCIAL OFFICER Cline Christopher R. exercised 20,000 shares at a strike of $17.44 and sold $3,148,544 worth of shares (50,508 units at $62.34) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 87,508 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVTX (Travere Therapeutics Inc.) and more on Quantisnow.